We are live on ! Find out more
MRKR icon

Marker Therapeutics
MRKR

48 hedge funds and large institutions have $7.36M invested in Marker Therapeutics in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 15 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.14% less ownership

Funds ownership: 2.81% → 2.66% (-0.14%)

2% less funds holding

Funds holding: 49 → 48 (-1)

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

28% less capital invested

Capital invested by funds: $10.3M → $7.36M (-$2.92M)

73% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 15

Holders
48
Holders Change
-1
Holders Change %
-2.04%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
15
Closed
6
Calls
$50K
Puts
–
Net Calls
+$50K
Net Calls Change
-$13K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$48K
2
MAA
Matrix Asset Advisors
New York
+$33.3K
3
Jane Street
Jane Street
New York
+$21.7K
4
TRCT
Tower Research Capital (TRC)
New York
+$7.42K
5
VF
Virtu Financial
New York
+$5.49K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
-$150K
2
Renaissance Technologies
Renaissance Technologies
New York
-$105K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$57.1K
4
BlackRock
BlackRock
New York
-$47K
5
Millennium Management
Millennium Management
New York
-$46.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$3.54M – – –
ACM
2
Aisling Capital Management
New York
$1.04M – – –
LFCM
3
Long Focus Capital Management
Puerto Rico
$804K – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$761K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$191K – – –
ACM
6
ACT Capital Management
Pennsylvania
$117K – – –
AAM
7
AR Asset Management
California
$92K – – –
Renaissance Technologies
8
Renaissance Technologies
New York
$88K -$105K -31,657 -54%
MAA
9
Matrix Asset Advisors
New York
$83K +$33.3K +10,000 +67%
BCM
10
Bridgeway Capital Management
Texas
$82K -$24.9K -7,500 -23%
State Street
11
State Street
Massachusetts
$62K -$665 -200 -1%
Creative Planning
12
Creative Planning
Kansas
$60K +$2.19K +660 +4%
Two Sigma Investments
13
Two Sigma Investments
New York
$58K -$26.8K -8,055 -31%
Citadel Advisors
14
Citadel Advisors
Florida
$48K +$48K +14,432 New
BlackRock
15
BlackRock
New York
$40K -$47K -14,141 -54%
Northern Trust
16
Northern Trust
Illinois
$36K – – –
MLIC
17
Mandatum Life Insurance Company
Finland
$33K – – –
WS
18
Wedbush Securities
California
$33K +$3.33K +1,000 +11%
Millennium Management
19
Millennium Management
New York
$30K -$46.7K -14,034 -60%
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
$27K -$5.35K -1,609 -16%
Jane Street
21
Jane Street
New York
$22K +$21.7K +6,538 New
Osaic Holdings
22
Osaic Holdings
Arizona
$16K -$333 -100 -2%
NRS
23
Neville Rodie & Shaw
New York
$10K – – –
IA
24
IFP Advisors
Florida
$9K – – –
PCA
25
Personal Capital Advisors
California
$8K – – –
1
2

MRKR Hedge Fund Activity: Q2 2022 in Review

48 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Marker Therapeutics (MRKR) for Q2 2022, worth a combined $7.36M — down 28% from $10.3M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of MRKR and 5 opened new positions — a net loss of 1 holder — while 15 trimmed existing stakes and 4 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $48K. The largest seller was Two Sigma Advisers, exiting entirely with an estimated $150K sold.

  • 48 institutional investors held Marker Therapeutics (MRKR) as of Q2 2022, down from 49 in Q1 2022.
  • Funds reported $7.36M of Marker Therapeutics stock for Q2 2022, down 28% quarter-over-quarter.
  • 5 funds opened new Marker Therapeutics positions in Q2 2022 and 6 closed out, a net change of -1 holder.
  • The largest Marker Therapeutics buyer in Q2 2022 was Citadel Advisors, an estimated $48K added.
  • The largest Marker Therapeutics seller in Q2 2022 was Two Sigma Advisers, an estimated $150K sold.

Based on aggregated 13F filings for Q2 2022.